IP Library Granted Patent US 11,056,239
Granted Patent B2
US 11,056,239 · App. 15/756,261 · Granted Jul 6, 2021

Risk-based monitoring of clinical data

Inventors: Badhri Srinivasan (Raleigh, NC); Joseph William Charles Goodgame (Chapel Hill, NC); Michael P. Arlotto (Chapel Hill, NC)
Assignee: REMARQUE SYSTEMS, INC.
G16H50/30G16H10/20G16H10/60G16H15/00G16H40/63G16H40/67G16H50/70G16H80/00H04L9/3247
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,056,239
App. No.
15/756,261
Granted
Jul 6, 2021
Kind
B2
Abstract

A computing device generates an audit trail for monitoring clinical data. In particular, the computing device receives clinical data comprising patient data and investigator site data. The computing device accepts and rejects respective portions of the clinical data by applying a risk-based monitoring policy comprising one or more policy rules to the clinical data. The computing device generates an audit trail for the clinical data. The audit trail comprises the clinical data and corresponding audit data. The audit data comprises identification of the accepted and rejected portions of the clinical data, identification of one or more of the policy rules of the risk-based monitoring policy used in the accepting and rejecting of the respective portions of the clinical data, and one or more timestamps corresponding to each of the accepting and rejecting of the respective portions.

Claims (55)

1. A method, implemented by a computing device, for generating an audit trail for monitoring clinical data, the method comprising:

receiving clinical data comprising patient data and investigator site data, wherein the investigator site data comprises safety metrics;

accepting and rejecting respective portions of the clinical data by applying a risk-based monitoring policy comprising one or more policy rules to the clinical data, wherein applying the risk-based monitoring policy comprises applying, to the clinical data, a machine-learning algorithm, wherein applying the machine-learning algorithm comprises:

learning, over time, patterns in the patient data and investigator site data of the clinical data;

receiving, over time, input from users regarding risk indicators in the learned patterns; and

maintaining, over time, a knowledge library based on the learned patterns and received input, wherein the accepting and rejecting of the portions of the clinical data is based on the maintained knowledge library;

generating an audit trail for the clinical data based on applying the risk-based monitoring policy to the clinical data, the audit trail comprising the clinical data and corresponding audit data, the audit data comprising:

identification of the accepted and rejected portions of the clinical data;

identification of one or more of the policy rules of the risk-based monitoring policy used in the accepting and rejecting of the respective portions of the clinical data;

one or more timestamps corresponding to when each of the accepting and rejecting of the respective portions took place.

2. The method of claim 1 , wherein applying the risk-based monitoring policy comprises applying, to the clinical data, one or more of a manual workflow or a predefined automated workflow.

3. The method of claim 1 , wherein the one or more policy rules comprises a policy rule that requires:

segmenting the clinical data into a relevant segment and a remainder;

identifying the relevant segment as being comprised in one of the accepted and rejected portions; and

timestamping one or more of the relevant segment and the remainder.

4. The method of claim 1 , wherein the audit data further comprises a digital signature certifying application of a corresponding policy rule identified in the audit data.

5. The method of claim 1 , wherein the patient data comprises, for at least one patient, demographic data, safety data, efficacy data and a medical history.

6. The method of claim 1 , wherein the investigator site data comprises productivity, quality, and risk for an investigated clinical site.

7. The method of claim 1 , further comprising configuring the risk-based monitoring policy by receiving a policy rule of the one or more policy rules from a user of the computing device.

8. The method of claim 1 , wherein the one or more of the policy rules comprises a policy rule that requires review of the clinical data by a medical reviewer and the generating of the audit trail for the clinical data.

9. The method of claim 1 , wherein the one or more of the policy rules comprises a policy rule that requires review of the clinical data by a statistical reviewer and the generating of the audit trail for the clinical data.

10. A computing device for generating an audit trail for monitoring clinical data, the computing device comprising:

interface circuitry configured to exchange signals over one or more data paths of the computing device;

processing circuitry communicatively coupled to the interface circuitry and configured to:

receive clinical data comprising patient data and investigator site data via the interface circuitry, wherein the investigator site data comprises safety metrics;

accept and reject respective portions of the clinical data by applying a risk-based monitoring policy comprising one or more policy rules to the clinical data, wherein applying the risk-based monitoring policy comprises applying, to the clinical data, a machine-learning algorithm, wherein applying the machine-learning algorithm comprises:

learning, over time, patterns in the patient data and investigator site data of the clinical data;

receiving, over time, input from users regarding risk indicators in the learned patterns; and

maintaining, over time, a knowledge library based on the learned patterns and received input, wherein the accepting and rejecting of the portions of the clinical data is based on the maintained knowledge library;

generate an audit trail for the clinical data based on applying the risk-based monitoring policy to the clinical data, the audit trail comprising the clinical data and corresponding audit data;

wherein the audit data comprises:

identification of the accepted and rejected portions of the clinical data;

identification of one or more policy rules of the risk-based monitoring policy used in the accepting and rejecting of the respective portions of the clinical data;

one or more timestamps corresponding to when each of the accepting and rejecting of the respective portions took place.

11. The computing device of claim 10 , wherein applying the risk-based monitoring policy comprises applying, to the clinical data, one or more of a manual workflow or a predefined automated workflow.

12. The computing device of claim 10 , wherein the one or more policy rules comprises a policy rule that requires:

segmenting the clinical data into a relevant segment and a remainder;

identifying the relevant segment as being comprised in one of the accepted and rejected portions; and

timestamping one or more of the relevant segment and the remainder.

13. The computing device of claim 10 , wherein the audit data further comprises a digital signature certifying application of a corresponding policy rule identified in the audit data.

14. The computing device of claim 10 , wherein the patient data comprises, for at least one patient, demographic data, safety data, efficacy data and a medical history.

15. The computing device of claim 10 , wherein the investigator site data comprises productivity, quality, and risk for an investigated clinical site.

16. The computing device of claim 10 , wherein the processing circuitry is further configured to configure the risk-based monitoring policy by receiving a policy rule of the one or more policy rules from a user of the computing device.

17. The computing device of claim 10 , wherein the one or more of the policy rules comprises a policy rule that requires review of the clinical data by a medical reviewer and the generating of the audit trail for the clinical data.

18. The computing device of claim 10 , wherein the one or more of the policy rules comprises a policy rule that requires review of the clinical data by a statistical reviewer and the generating of the audit trail for the clinical data.

19. A non-transitory computer readable medium storing a computer program product for controlling a programmable computing device in a communication network, the computer program product comprising software instructions that, when run on the programmable computing device, cause the programmable computing device to:

receive clinical data comprising patient data and investigator site data via interface circuitry, wherein the investigator site data comprises safety metrics;

accept and reject respective portions of the clinical data by applying a risk-based monitoring policy comprising one or more policy rules to the clinical data, wherein applying the risk-based monitoring policy comprises applying, to the clinical data, a machine-learning algorithm, wherein applying the machine-learning algorithm comprises:

learning, over time, patterns in the patient data and investigator site data of the clinical data;

receiving, over time, input from users regarding risk indicators in the learned patterns; and

maintaining, over time, a knowledge library based on the learned patterns and received input, wherein the accepting and rejecting of the portions of the clinical data is based on the maintained knowledge library;

generate an audit trail for the clinical data based on applying the risk-based monitoring policy to the clinical data, the audit trail comprising the clinical data and corresponding audit data, the audit data comprising:

identification of the accepted and rejected portions of the clinical data;

identification of one or more policy rules of the risk-based monitoring policy used in the accepting and rejecting of the respective portions of the clinical data;

one or more timestamps corresponding to when each of the accepting and rejecting of the respective portions took place.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2024
From: CAPITAL ONE
To: REMARQUE SYSTEMS, INC.
Reel/Frame 066769/0322 →
SECURITY INTEREST Recorded Mar 14, 2024
From: REMARQUE SYSTEMS, LLC
To: HAYFIN SERVICES LLP
Reel/Frame 066774/0805 →
SECURITY INTEREST Recorded Jun 21, 2021
From: REMARQUE SYSTEMS, INC.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 056600/0790 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2018
From: SRINIVASAN, BADHRI; GOODGAME, JOSEPH WILLIAM CHARLES; ARLOTTO, MICHAEL P.
To: REMARQUE SYSTEMS, LLC
Reel/Frame 045064/0816 →
CHANGE OF NAME Recorded Feb 28, 2018
From: REMARQUE SYSTEMS, LLC
To: REMARQUE SYSTEMS, INC.
Reel/Frame 045471/0989 →
Continuity (2)
Provisional Application 62214505 · Sep 4, 2015
Related Publication 20180240553A1 · Aug 23, 2018